DIRC3-IGFBP5 is a shared genetic risk locus and therapeutic target for carpal tunnel syndrome and trigger finger

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was conducted using the UK Biobank resource under application number 22572. We thank all patients and their families who have volunteered to participate in clinical research. We thank the Oxford Genomics Centre at the Wellcome Centre for Human Genetics (funded by Wellcome Trust grant reference 203141/Z/16/Z) for the generation and initial processing of RNA sequencing data. We also thank our clinical collaborators of the NDOMRS Hand Research Group for the collection of surgical specimens (https://www.ndorms.ox.ac.uk/ research-groups/collaborative-hand-research-group). S.O.K. is supported by the Starr Centennial Scholarship at the Cold Spring Harbor Laboratory School of Biological Sciences. Computational analyses at Cold Spring Harbor Laboratory were performed with assistance from the US National Institutes of Health Grant S10OD028632-01. A.W. is supported by a NIHR Clinical Lectureship and a grant from the MRC DTP (MR/N013468/1). D.F. is supported by the NIHR Biomedical Research Centre, Oxford (BRC). A.S. is supported by a Wellcome Trust Clinical Career Development Fellowship (222101/Z/20/Z) and the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

UK Biobank has approval from the North West Multi-Centre Research Ethics Committee (11/NW/0382), and this study (Genetics and Epidemiology of Common Hand Conditions/GECHCo) has UK Biobank study ID 22572. The Oxford-CTS cohort is derived from two clinical studies approved by the National Research Ethics Service, United Kingdom - Pain in Neuropathy Study (PiNS, 10/H07056/35) and Molecular Genetics of Carpal Tunnel Syndrome (MGCTS, 16/LO/1920).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes